Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 4, No 5 (2008) COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
"... Aim. To assess efficacy and safety of generic simvastatin, Simvahexal, in comparison with original ..."
 
Vol 7, No 6 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich
"... simvastatin TC decreased from 6.4±0.8 to 4.4±0.6 mmol/l (p<0.001) and from 6.0±0.7 to 4.1±0.7 mmol/l (p<0.001 ..."
 
Vol 7, No 5 (2011) COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN Abstract  similar documents
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk
"... ) received generic simvastatin. Initial simvastatin dose was 20 mg daily. Lipid plasma profile, liver enzymes ..."
 
Vol 6, No 4 (2010) EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK Abstract  similar documents
N. V. Perova, E. I. Sokolov, G. N. Shchukina, V. A. Metelskaya
"... . Requirements for generics of one of the widely used statin, simvastatin, are discussed. Data of several studies ..."
 
Vol 9, No 6 (2013) EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE Abstract  similar documents
T. V. Pinchuk, Y. N. Fedulaev, G. A. Khairetdinova, A. A. Kozina, V. N. Ryzhenkov, N. M. Ahmedzhanov
"... early diastolic left ventricular filling velocity) value by 14.1% (p<0.001) and E/A (where A - peak left ..."
 
Vol 11, No 2 (2015) NEWS OF EVIDENCE-BASED MEDICINE: RESULTS OF THE IMPROVE-IT TRIAL AND THEIR IMPLICATIONS FOR CLINICAL PRACTICE Abstract  similar documents
S. Yu. Martsevich
 
Vol 1, No 3 (2005) EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
J. E. Semyonova, S. Y. Martsevich, N. V. Perova, A. M. Olferiev, N. P. Kutishenko, N. Y. Ivanenkova, N. A. Dmitrieva, A. A. Serazhim
"... with atorvastatine generic, Tulip, in comparison with simvastatine generic, Vasilip, in hyperlipidemic patients ..."
 
Vol 5, No 3 (2009) ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT Abstract  similar documents
V. N. Isakova, O. G. Garbuzova, E. V. Klinkova, E. V. Bandurko
"... with moderate/high cardiovascular risk receiving lisinopril and simvastatin. Material and methods. 20 patients ..."
 
Vol 9, No 4 (2013) EFFECT OF SIMVASTATIN ON THE PROGNOSIS AND THE CHANGES OF THE CLINICAL STATUS IN PATIENTS WITH ACUTE ISCHEMIC STROKE. THE RESULTS OF THE 12 MONTH RANDOMIZED, OPEN COMPARATIVE STUDY Abstract  similar documents
V. V. Yakusevich, A. Yu. Malygin, A. V. Kabanov
"... in patients with the first ischemic stroke of hemispheric localization after prescription of simvastatin 40 mg ..."
 
Vol 2, No 4 (2006) POSTMENOPAUSAL METABOLIC SYNDROME: CORRECTION OF AUTONOMIC NERVOUS SYSTEM DISBALANCE WITH COMBINATION OF ACE-INHIBITOR AND STATIN Abstract  similar documents
I. V. Logacheva, E. N. Shustova, E. V. Kulinich
"... in response on combined therapy with fosinopril and simvastatin in postmenopausal metabolic syndrome (MS ..."
 
Vol 8, No 1 (2012) THE EFFICACY OF HIGH-DOSE SIMVASTATIN IN ACUTE PERIOD OF ISCHEMIC STROKE Abstract  similar documents
V. V. Yakusevich, A. Yu. Malygin, S. V. Lychenko, A. S. Petrochenko, A. V. Kabanov
"... stroke treated with simvastatin 40 mg/day in acute period of the disease. Materials and methods ..."
 
Vol 12, No 6 (2016) THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 Abstract  PDF (Eng)  PDF (Eng)  similar documents
S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov
"... and very high risk, respectively. In-hospital rate of simvastatin administration reduced from 33.6% to 0 ..."
 
Vol 8, No 2 (2012) COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
O. P. Bobrova, M. M. Petrova
"... in the blood plasma 5.42 (5.26–5.76) vs 4.88 (4.86–4.94) hours, respectively; p<0.001. Original enalapril ..."
 
Vol 7, No 2 (2011) A COMPARATIVE STUDY OF THE EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN MONOTHERAPY OR IN COMBINATION WITH S-AMLODIPINE AND INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 DEGREES. RESULTS OF THE CLINICAL RANDOMIZED CROSSOVER STUDY Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, I. V. Vashurina
"... Hg in group 2 (p<0.001 for both groups), intergroup differences were insignificant. Target BP levels ..."
 
Vol 6, No 4 (2010) COMPARISON OF CLINICAL EFFICACY OF ORIGINAL BISOPROLOL AND ITS GENERIC DRUG IN PATIENTS WITH STABLE ANGINA AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE Abstract  similar documents
N. Yu. Grigorieva, E. G. Sharabrin, A. N. Kuznetsov
"... reduction from 98.6±2.5 to 58.6±3.5 bt/min (р<0.001) was found with the 24 hour electrocardiogram-monitoring ..."
 
Vol 14, No 1 (2018) STUDY OF CLINICAL EFFICACY OF ORIGINAL AND GENERIC DRUGS OF IVABRADINE IN PATIENTS WITH STABLE ANGINA (СOMPARATIVE STUDY) Abstract  similar documents
S. V. Povetkin, Ju. V. Luneva
"... Aim. To study the therapeutic efficacy and safety of generic drug of ivabradine in comparison ..."
 
Vol 14, No 6 (2018) Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation Abstract  PDF (Eng)  similar documents
A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee
"... represented by generics. As for statins, only simvastatin could be found in almost all pharmacies. When ..."
 
Vol 6, No 4 (2010) HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD Abstract  PDF (Eng)  similar documents
A. A. Abdullaev, R. M. Gafurova, U. A. Islamova, I. A. Kadieva, R. G. Khabchabov
"... to the first and to control groups. In the second group LF increased from 223.8±56.2 to 734±90.9 мs2 (p<0.001 ..."
 
Vol 11, No 6 (2015) Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon? Abstract  similar documents
I. A. Latfullin, L. F. Galiullina, I. Z. Rakhmatullin, V. V. Klochkov, A. V. Aganov
"... and simvastatin with model of cell membrane were studied by method of nuclear magnetic resonance spectroscopy ..."
 
Vol 16, No 5 (2020) Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko
"... Aim. To perform a pharmacoeconomical assessment of the use of generic statin drugs in patients ..."
 
Vol 9, No 5 (2013) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL LOW-DOSE BISOPROLOL/HYDROCHLOROTHIAZIDE COMBINATION IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREES. RESULTS OF CLINICAL RANDOMIZED CROSSOVER STUDY Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, A. V. Zakharova, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, N. V. Kiseleva
"... Aim. To study the clinical equivalence of the two low-dose combined drugs on the base of generic ..."
 
Vol 4, No 4 (2008) ECONOMIC REASONS FOR GENERIC CHOICE Abstract  similar documents
N. P. Kutishenko, S. Y. Martsevich, S. N. Tolpygina, J. V. Lukina
"... Many generic medicines appear in the pharmaceutical market now. However, they are not always ..."
 
Vol 4, No 1 (2008) ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... Guidelines are discussed. Problem of statin choice and problem of equivalence of generic drugs to original ..."
 
Vol 12, No 1 (2016) A comparative study of the efficacy and safety of the original and generic orlistat in obese patients in the PROFIL register Abstract  similar documents
A. V. Zakharova, S. N. Tolpygina, V. P. Voronina, S. Yu. Martsevich
"... Aim. To study the efficacy and safety of generic orlistat in comparison with the original drug ..."
 
Vol 13, No 6 (2017) SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS Abstract  similar documents
I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova
"... before admission: atorvastatin (10-40 mg/day), simvastatin (20-40 mg/day), rosuvastatin (10-40 mg/day ..."
 
Vol 13, No 2 (2017) STATINS AND THEIR INTERACTION WITH MODEL CELL MEMBRANES ACCORDING TO THE DATA OF NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY Abstract  similar documents
I. A. Latfullin, L. F. Galiullina, G. S. Musabirova, O. V. Aganova, Z. F. Kim, A. V. Aganov, V. V. Klochkov
"... Aim. To study the location of pravastatin, simvastatin, fluvastatin and cerivastatin in molecular ..."
 
Vol 5, No 1 (2009) PROBLEM OF GENERIC REPLACEMENT: ADVANTAGES AND DISADVANTAGES Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich
"... The main differences between original and generic drugs as well as registration criteria ..."
 
Vol 5, No 6 (2009) STATIN GENERICS: EFFICACY AND SAFETY RATIO Abstract  similar documents
V. P. Voronina, A. A. Serazhim, A. V. Zagrebelnyi, S. Yu. Martsevich, S. A. Shalnova
"... choice between original and generic drugs is discussed taking into account efficacy and safety ratio. ..."
 
Vol 7, No 1 (2011) THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS Abstract  similar documents
O. V. Gaisenok
"... of the clopidogrel generics appearance and prospects of their use is presented. ..."
 
Vol 5, No 6 (2009) ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS WITH AMLODIDINE: ORIGINAL DRUG VERSUS GENERIC Abstract  similar documents
S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, L. A. Sokolova, V. V. Jakusevich, J. V. Lukina, M. A. Maximova, A. V. Zaharova, A. A. Serazhim, V. P. Voronina
"... Aim. To evaluate antihypertensive effects of new generic amlodipine (Stamlo M) in comparison ..."
 
Vol 5, No 6 (2009) ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS Abstract  similar documents
N. A. Dmitrieva, S. N. Tolpygina
"... ) in cardiologic practice are presented. The special attention is given to generic drugs of ACA. Their application ..."
 
Vol 7, No 2 (2011) WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, I. V. Vashurina
"... The problem of generic drugs use in clinical practice and confirmation of their therapeutic ..."
 
Vol 6, No 1 (2010) COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, A. A. Serazhim, V. P. Voronina, M. A. Maksimova, L. Yu. Drozdova, A. V. Zakharova
"... Aim. To compare efficacy of ramipril generic Hartil® (Egis) to original drug Tritace® in patients ..."
 
Vol 2, No 2 (2006) PROBLEM OF TREATMENT WITH STATINS IN RUSSIA: WILL GENERICS HELP? Abstract  similar documents
S. Y. Martsevich
"... of generic-statins equivalence to original drugs is considered. ..."
 
Vol 1, No 1 (2005) ASSESSMENT OF QUALITY OF GENERICS IN CARDIOLOGY: REALITY AND POSSIBILITIES Abstract  similar documents
V. V. Yakusevich
"... Wide presence of original drugs’ copies, the so-called “generics”, on the pharmaceutical market ..."
 
Vol 6, No 2 (2010) THE MODERN ASPECTS OF CLOPIDOGREL USE Abstract  similar documents
E. N. Dankovtseva, D. A. Zateyshchikov
"... complications are presented. The results of the comparative trails of original and generic clopidogrel are also ..."
 
Vol 6, No 6 (2010) COMBINATION THERAPY OF HYPERTENSION — A RELIABLE WAY TO TARGET ACHIEVE Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... of therapeutic efficacy and safety of combined antihypertensive therapy based on generics are important ..."
 
Vol 7, No 6 (2011) COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES Abstract  similar documents
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk
"... +indapamide, patients of group B (n=30) — a fixed combination of the generic enalapril+indapamide, patients ..."
 
Vol 10, No 4 (2014) PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE Abstract  similar documents
E. I. Tarlovskaya, Y. A. Balandina, N. S. Maximchuk-Kolobova
"... – with double dose. In group B (non-fixed combination of generic enalapril/indapamide) 60% of patients achieved ..."
 
Vol 3, No 2 (2007) ASSESSMENT OF THERAPEUTICAL EQUIVALENCY OF ORIGINAL AND GENERIC INDAPAMIDE IN HYPERTENSIVE PATIENTS BY RANDOMIZED CROSS-OVER STUDY Abstract  similar documents
N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, S. Y. Martsevich
"... Aim. To develop a protocol for comparison of efficacy and safety of original drugs with generic ..."
 
Vol 8, No 4 (2012) THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
L. E. Chekuldaeva, S. V. Obuhova, A. A. Simakov, L. V. Poljaeva, E. I. Rjazanova
 
Vol 8, No 2 (2012) THE KARDIOKANON STUDY: A WAY TO SETTLE THE SUBJECT OF CLINICAL EQUIVALENCE OF GENERIC AND ORIGINAL DRUGS Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, M. L. Ginzburg, G. V. Matyushin, V. V. Skibitskiy, L. A. Sokolova, A. V. Deev
"... Aim. To compare two therapies based on the use of original or generic drugs in patients ..."
 
Vol 14, No 6 (2018) Assessment of in Vitro Comparative Dissolution Kinetics of Moxonidine Products as a Factor Potentially Determining Effectiveness of Antihypertensive Treatment Abstract  PDF (Eng)  similar documents
G. V. Ramenskaya, I. E. Shokhin, N. I. Gaponova, V. R. Abdrakhmanov
"... Aim. Investigation of comparative dissolution kinetics of generic medicinal products containing ..."
 
Vol 7, No 1 (2011) THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY Abstract  similar documents
V. V. Yakusevich, A. S. Petrochenko, V. A. Simonov, N. Yu. Levshin, A. D. Deev
"... (Plavix) and its generic (Egitromb) in patients of high cardiovascular risk. Material and methods. Thirty ..."
 
Vol 7, No 1 (2011) THE CHOICE OF THE DRUG AMLODIPINE FOR THE HYPERTENSION TREATMENT FROM THE STANDPOINT OF ECONOMIC FEASIBILITY Abstract  similar documents
S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, Yu. V. Lukina, L. A. Sokolova, V. V. Yakusevich
"... Aim. Тo compare the cost-effectiveness of antihypertensive therapy based on a generic and original ..."
 
Vol 9, No 5 (2013) THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL Abstract  similar documents
A. I. Malyhina, M. V. Zhuravleva, A. K. Starodubtsev, M. L. Maksimov, O. A. Rogacheva
"... Aim. To evaluate the therapeutic equivalence between generic perindopril (Parnavel, LLC Ozone ..."
 
Vol 7, No 4 (2011) VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, Zh. D. Kobalava, E. K. Shavarova
"... Aim. To study the therapeutic equivalence of original and generic fosinopril in patients ..."
 
Vol 12, No 2 (2016) COMPARATIVE PHARMACOKINETICS AND EFFECT ON THE HEMODYNAMICS OF ORIGINAL AND GENERIC NEBIVOLOL IN HEALTHY VOLUNTEERS Abstract  similar documents
E. I. Bambysheva, K. V. Isaeva, M. M. Makhinova, D. T. Guranda, V. G. Belolipetskaya
"... of generics into clinical practice requires clear evidence of bioequivalence to the original drug. Aim ..."
 
Vol 6, No 4 (2010) ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? Abstract  similar documents
D. V. Nebieridze, A. S. Safarian
 
Vol 6, No 6 (2010) COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina
"... Aim. To compare the antiplatelet efficacy of the original and generic enterosoluble tableted ..."
 
Vol 3, No 3 (2007) COMPARATIVE EVALUATION OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE Abstract  similar documents
S. N. Tolpygina, E. V. Shilova, S. Y. Martsevich
"... ) and generic (Bisogamma, WORWAG PHARMA GmbH & Co) bisoprolol were investigated in open-label cross-over ..."
 
Vol 8, No 2 (2012) UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev
 
Vol 4, No 1 (2008) COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE Abstract  similar documents
N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich
"... by therapies. There were not significant inter-group differences. Conclusion. ASA generic medicine Acecardol ..."
 
Vol 2, No 4 (2006) QUALITATIVE DRUG: WHAT SHOULD IT LOOK LIKE? Abstract  similar documents
V. V. Iakusevich
"... reduction is also connected with a huge number (80%) of reproduced drugs (generics). Considerable part among ..."
 
Vol 13, No 2 (2017) SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
"... .32% of patients, enalapril 20 mg/day – 30.45%, simvastatin and atorvastatin 20 mg/day – 64.52% and 47 ..."
 
Vol 15, No 5 (2019) Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis Abstract  similar documents
L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok
"... group were older than these in the first group (p<0.001). Patients of the group 1 compared to the group ..."
 
Vol 11, No 3 (2015) ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta
"... with simvastatin, in 75.2% of the patients treated with atorvastatin, in 59% of the patients treated ..."
 
Vol 3, No 5 (2007) CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION Abstract  similar documents
N. A. Belolipetskiy, S. N. Tolpygina, J. B. Zverkov, V. V. Pisarev, I. E. Koltunov, V. G. Belolipetskaya, S. J. Martsevich
"... with cost of 727 rbl/month for Norvasc therapy. Conclusion. Generic Amlorus showed clinical ..."
 
Vol 4, No 3 (2008) ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES Abstract  similar documents
E. I. Bambysheva, S. N. Tolpygina, D. F. Guranda, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich
"... ) and of generic (VedicardolR, ≪Synthesis≫, Russia) carvedilols with estimation of their serum level. And to study ..."
 
Vol 9, No 1 (2013) FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Ya. Bart, E. A. Vartanyan
"... (p<0.001), they were more often diagnosed with left ventricular aneurysm (p=0.001), chronic kidney ..."
 
Vol 14, No 6 (2018) Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan
"... Aim. To study adherence to treatment with generic statins prescribed to patients with high and very ..."
 
Vol 12, No 1 (2016) Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease Abstract  similar documents
E. I. Tarlovskaya, T. I. Chudinovskikh
"... Aim. To compare the efficacy and cost/effectiveness ratio of the original and generic bisoprolol ..."
 
Vol 9, No 2 (2013) INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS –SIMPLE SOLUTIONS Abstract  similar documents
Zh. M. Sizova
"... and generic drugs. The study showed clinical equivalence of the generic DeprenormR (Canonpharma Production ..."
 
Vol 1, No 3 (2005) CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL Abstract  similar documents
M. A. Statsenko, I. A. Sporova, S. V. Belenkova, N. N. Shilina
"... , simvastatin and diuretics were randomized to either bisoprolol (n=20) or сarvedilol (n=20) therapy group ..."
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... : acetylsalicylic acid 100 mg – up to 71.1%, simvastatin and atorvastatin 20 mg – up to 60.5% and 41 ..."
 
Vol 16, No 2 (2020) Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries Abstract  similar documents
O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich
"... with myocardial infarction (MI) according to RECORD-3 are more often male smokers (p=0.001) with a heredity ..."
 
Vol 9, No 4 (2013) EFFECT OF IRON AND SELENIUM DRUGS ON DIASTOLIC MYOCARDIAL FUNCTION IN PATIENTS WITH ANEMIC CARDIOMYOPATHY Abstract  similar documents
E. V. Goncharova, A. V. Govorin
"... with cardiomyopathy. Flow rate rapid filling re- duced by 27.1% compared with this in control (p<0.001), and flow rate ..."
 
Vol 5, No 5 (2009) EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Y. Bart, M. P. Mikhaylusova, B. N. Mamtsev
"... -diastolic dimension (p<0,001), end-systolic dimension (p<0,001), left atrium (p=0,004), end-diastolic vol ..."
 
Vol 8, No 1 (2012) THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, V. P. Voronina, L. Yu. Drozdova
"... Aim. To study the efficacy and safety of generic valsartan Valz (Actavis Group, Iceland ..."
 
Vol 16, No 3 (2020) The Short-Term Effect of Stent Size and Number on Left Ventricular Systolic Function Improvement After Elective Percutaneous Coronary Intervention Abstract  PDF (Eng)  similar documents
Sh. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk
"... .94%. One month after PCI, mean GLPSS improved significantly to -14.05±1.72% (p<0.001), 3 months after PCI ..."
 
Vol 9, No 3 (2013) ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING Abstract  similar documents
N. S. Maksimchuk-Kolobova, E. I. Tarlovskaya, S. V. Malchikova
 
Vol 12, No 1 (2016) Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease Abstract  PDF (Eng)  similar documents
E. I. Leonova, G. G. Shechyan, V. S. Zadionchenko, T. V. Adasheva, A. D. Deev, I. V. Fedorova
"... .356; p=0.011), CRP level (R=0.442; p=0.001), the sizes of both atria (p<0.001), isovolumic relaxation ..."
 
Vol 12, No 6 (2016) EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... myocardial mass (from 170 [225.5;213.5] to 159 [146;167] g; p<0.001), and size of the left atrium (LA; from ..."
 
Vol 10, No 3 (2014) EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... <0.001) were revealed. The right ventricle increased in size with the impairment of its diastolic ..."
 
Vol 7, No 5 (2011) EFFECT OF ERYTHROPOIETIN ON THE CLINICAL COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH ANEMIA: RESULTS OF NOT COMPARATIVE STUDY Abstract  similar documents
V. M. Provotorov, S. A. Avdeeva
"... increase in hemoglobin (+12.5%; p<0.001) and hematocrit (+5.8%; p<0.001) levels, as well as increase in red ..."
 
Vol 15, No 3 (2019) Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko
"... valve in patients of groups 1 and 2 was lower than in the control by 15% and 17%, respectively (p<0.001 ..."
 
Vol 15, No 6 (2019) Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo) Abstract  similar documents
D. Yu. Sedykh, V. V. Kashtalap, R. M. Velieva, O. L. Barbarash
"... disease and polyvascular disease (р=0.002), prior angina pectoris (р=0.001), as well as the course ..."
 
Vol 13, No 4 (2017) COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina
"... volume (p<0.01),right ventricle anterior-posterior dimension (p<0.001), right atrium volume (p<0.01 ..."
 
Vol 8, No 4 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... .8±8.4 and -30.4±12.8/18.7±8 mm Hg for groups 1 and 2, respectively , p<0.001 for the both groups ..."
 
Vol 6, No 4 (2010) EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA Abstract  similar documents
P. Ya. Dovgalevsky, V. A. Klochkov, N. E. Chalyk, O. M. Ansimova, I. Petyaev
"... application led to significant reduction in levels of TC (from 247.1±27 to 186.5±12 mg/dl; p<0.001), LDC (from ..."
 
Vol 6, No 5 (2010) INTERRELATION BETWEEN PERSISTENT NECROSIS OF CARDIOMYOCYTES AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  PDF (Eng)  similar documents
E. N. Golovenko, D. A. Napalkov, V. A. Sulimov
"... (FC) III-IV than in those with CHF of FC I-II (p<0.001). Negative correlation was revealed between TrI ..."
 
Vol 16, No 4 (2020) Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist Abstract  PDF (Eng)  similar documents
S. I. Farag, O. S. Arafa, A.A. E. Hassan, H. M. Mashhour, A. M. Bendary
"... (TTR≥65%) were younger (p<0.001), more often men (p<0.074) with a high level of education (p<0.001 ..."
 
Vol 15, No 2 (2019) Remodeling of the Pulmonary Circulation in Patients with Viral Liver Cirrhosis Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko
"... - 0.9 [0.8;1.31 ], in the 2nd group - 0.8 [0.78; 1.2] with a control value of 1.6 [1.2;1.94] (p<0.001 ..."
 
Vol 2, No 4 (2006) REPORT ON OPEN MULTICENTRAL RESEARCH PROGRAM “PRIORITY” IN CLINICAL PRACTICE. (PEKTROL – QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA PECTORIS TREATED WITH ISOSORBIDE-5-MONONITRATE IN LONG-ACTING PRESENTATION) Abstract  similar documents
Yu. A. Karpov
"... protocol. The treatment with ISMN reduced the frequency and duration of angina attacks (p<0,001 ..."
 
Vol 11, No 3 (2015) THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION Abstract  similar documents
I. L. Tepoyan, D. V. Nebieridze, I. A. Skripnikova, A. S. Safaryan, V. A. Vygodin, V. E. Novikov, L. M. Murashko
"... increase in BMD in the spine according to the T-test from -1.7±0.4 SD to -1.4±0.53 SD (p<0.001), while ..."
 
Vol 14, No 2 (2018) MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov
"... density cholesterol (LDC) by 52.4% (p<0.001) was found after 24 weeks in Group 1. Achieving the target LDC ..."
 
Vol 7, No 6 (2011) EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS Abstract  similar documents
V. E. Oleynikov, I. B. Matrosova, Y. A. Tomashevskaya, L. I. Gusakovskaya, E. A. Melnikova
"... Hg; p<0.001; dyastolic BP decreased from 90 (87;93) to 80 (77;84) mm Hg; p<0.001 ..."
 
Vol 14, No 5 (2018) Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome Abstract  PDF (Eng)  similar documents
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal
"... , triglyceride (p<0.001) and significant increase in high-density lipoprotein cholesterol (p<0.001) when compared ..."
 
Vol 13, No 5 (2017) COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES Abstract  similar documents
A. N. Sumin, E. V. Korok, A. V. Shcheglova, O. L. Barbarash
"... and more often had excess body weight (p<0.001). The majority of current smokers were males (p<0.001 ..."
 
Vol 15, No 5 (2019) Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION) Abstract  similar documents
E. Yu. Okshina, M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, N. P. Kutishenko, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina
"... a hypercholesterolemia – 47% and 59.7% (p<0.001). The incidence of drug administration with proved positive prognostic ..."
 
Vol 15, No 1 (2019) Prognostic Value of ECG in Patients with Pulmonary Embolism Abstract  similar documents
I. S. Mullova, T. V. Pavlova, S. M. Khokhlunov, D. V. Duplyakov
"... -complete right bundle branch block (RBBB) (16.3 vs 37.9%; p=0.001), ST segment elevation in lead III (9 ..."
 
Vol 2, No 1 (2006) ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE Abstract  similar documents
R. M. Linchak, K. M. Shumilova, A. D. Martinyuk, T. A. Gusaim, E. V. Semyonova, L. G. Zhirova, S. A. Boitsov
"... in 24 hrs. (from 141.9±1.9 to 128.6±0.8 mmHg, p<0.001), in daytime (from 146.8±2.6 to 135.8±1.0 mmHg, p ..."
 
Vol 9, No 6 (2013) COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY Abstract  similar documents
I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko
"... .05). Group 4: the average CHF class decreased by 41.4% (p<0.001), EF increased by 32.8% (p<0.001). Conclusion ..."
 
Vol 8, No 6 (2012) THE EFFECT OF MAGNESIUM DRUGS ON THE PHYSICAL PERFORMANCE OF YOUNG PEOPLE WITH MITRAL VALVE PROLAPSE: RESULTS OF NONCOMPARATIVE STUDY Abstract  similar documents
K. M. Dzeranova, A. G. Avtandilov, N. V. Vertkina
"... product elevated from 1.86±0.05 to 2.06±0.05 units (p<0.001); threshold power increased - relative ..."
 
Vol 14, No 1 (2018) IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION Abstract  similar documents
I. V. Sergienko, A. A. Ansheles
"... .3%, "probable" – 18.1%. Patients with definite FH diagnosis showed higher level of TCh (p<0.001), LDL ..."
 
Vol 7, No 6 (2011) MITRAL ANNULAR CALCIFICATION IN ELDERLY PATIENTS. CLINICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS Abstract  similar documents
N. S. Chipigina, G. M. Urvacheva, N. A. Shostak, I. V. Zhitareva, I. Yu. Zhitomirskaya
"... associations of MAC presence with symptomatic atherosclerotic peripheral arterial disease (p <0.001; ß=0 ..."
 
Vol 8, No 5 (2012) HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... with the control group women had higher values of minimum (52.3±0.4 vs 47.5±0.4; p<0.001) and mean (78.5±0.5 vs 75 ..."
 
Vol 15, No 5 (2019) Left Atrial Phasic Function in Patients with Hypertension and Recurrent Atrial Fibrillation: Gender Differences of the Relationship with Diastolic Dysfunction and Central Aortic Pressure Abstract  similar documents
E. V. Kokhan, E. M. Ozova, V. A. Romanova, G. K. Kiyakbaev, Zh. D. Kobalava
"... [42;55]%; p=0.02) and E/E’(9.7 [7.8;12] vs 7.1 [5.6;8.6]; p=0.001) were worse than in men. Active LA ..."
 
Vol 13, No 3 (2017) ROLE OF PULMONARY HYPERTENSION IN THE DEVELOPMENT OF CIRRHOTIC CARDIOMYOPATHY Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... , and reduced mean blood-flow velocity in the portal vein (p<0.001). According to the DEchoCG data, in patients ..."
 
1 - 100 of 324 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)